m****g
发帖数: 530 | 1 BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Mar 31, 2010 - Genta Incorporated (
OTCBB: GETA) today
announced that the Company has initiated a confirmatory Phase 2b trial of
tesetaxel in patients with
advanced gastric cancer. Tesetaxel is the Company's newest clinical-stage
small molecule. As a late Phase
2 oncology product, tesetaxel is the leading oral taxane currently in
clinical development. The trial is
currently open to enrollment at Northwestern University, Chicago, IL, which
will be joined b |
|
